JMKX-000623

N/A

Report date: 2024/05/06 14:10:51
NME

Base Information

Drug NameJMKX-000623
Drug Alias NameJMKX000623JMKX-000623ODM-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPainDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Jiyu Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesOrion CorpJiangxi Jemincare Group Co Ltd
Inactive CompaniesShanghai Jiyu Pharmaceutical Technology Co Ltd
Active IndicationsPainDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A